Search Results 1961-1970 of 14757 for anti-TNF drugs

1. Menthol And Zinc Oxide (Topical Application Route) Before Using - Mayo Clinic

   Allergies. Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care ...

2. A Study Assessing Compliance with Mercaptopurine Treatment in Children with Acute Lymphoblastic Leukemia in First Remission - Mayo Clinic

   This randomized phase III trial studies compliance to a mercaptopurine treatment intervention compared to standard of care in younger patients with acute ...

3. Research Tool Used in Prostate Cancer May Lead to New Therapies - Mayo Clinic News Network

   D. This makes targeting transcription factors a promising strategy for cancer treatment. But researchers have struggled because most transcription factors lack ...

4. A Study of the Combination of Talquetamab and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... anti-CD38 mAb; (b) Documented evidence of ... * All Parts: Targeted therapy, epigenetic therapy, or treatment ...

5. Lenvatinib (Oral Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

6. Entecavir (Oral Route) Description and Brand Names - Mayo Clinic

   Descriptions. Entecavir is used to treat liver infection caused by hepatitis B virus. It belongs to the family of medicines called antivirals. Antivirals are ...

7. Nimodipine (Oral Route) Precautions - Mayo Clinic

   Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines ...

8. Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma - Mayo Clinic News Network

   The study is published in Cancer Discovery. "CAR-T cell therapy is a promising treatment for non-Hodgkin lymphoma, especially for patients who have relapsed or ...

9. Umbralisib (Oral Route) Description and Brand Names - Mayo Clinic

   ... treatment (refractory) in patients who have received at least one previous treatment (eg, anti-CD20-based treatment). It is also used to treat follicular ...

10. Pilot Study of ACTH in the Treatment of IgA Nephropathy at High Risk of Progression - Mayo Clinic

    This study is designed to answer whether patients with progressive IgA nephropathy, who receive Acthar (ACTH) gel injection at a dose of 80 units subcutaneously ...